Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neuromolecular medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1385/NMM:4:1-2:1PMID 14528048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Excitotoxic and excitoprotective mechanisms

  2007cited by this paper
• Application of chemical chaperones to the rescue of folding defects.

  2003cited by this paper
• Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

  2003cited by this paper
• Unfolding the role of protein misfolding in neurodegenerative diseases

  2003influential reference
• Parkinson's Disease and Related α‐Synucleinopathies Are Brain Amyloidoses

  2003cited by this paper
• Toxic Proteins in Neurodegenerative Disease

  2002cited by this paper
• Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior.

  2002cited by this paper
• Alzheimer's disease-do tauists and baptists finally shake hands?

  2002cited by this paper
• Pharmacological prevention of Parkinson disease in Drosophila

  2002cited by this paper
• The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.

  2002cited by this paper
• "Emerging Alzheimer's disease therapies: focusing on the future".

  2002cited by this paper
• Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002influential reference
• Chaperoning brain degeneration

  2002cited by this paper
• Alzheimer Disease Therapeutics

  2001cited by this paper
• Neurodegenerative tauopathies.

  2001cited by this paper
• Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease

  2001influential reference
• “Fatal Attractions” of Proteins: A Comprehensive Hypothetical Mechanism Underlying Alzheimer's Disease and Other Neurodegenerative Disorders

  2000cited by this paper
• Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

  2000cited by this paper
• Treatment of Alzheimer's disease.

  1999cited by this paper
• Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau

  1998cited by this paper
• Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau

  1998cited by this paper
• Amyloid, the presenilins and Alzheimer's disease.

  1997cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997cited by this paper
• Treatment for Alzheimer's disease?

  1992cited by this paper
• Amyloid deposition as the central event in the aetiology of Alzheimer's disease.

  1991cited by this paper

• Plasma extracellular vesicles and phosphorylated tau 181 as early biomarkers of cognitive impairment in Alzheimer’s dementia

  2026cites this paper
• Biochanin-A: A Potential Candidate for the Treatment of Alzheimer's Disease.

  2025cites this paper
• Small molecule inhibitors targeting alpha-synuclein aggregation: Progress and future outlook.

  2025cites this paper
• An Overview of Neuroprotective Effects of Erythropoietin Against Neurological Disorders: Beyond Erythropoiesis

  2025cites this paper
• Energetic failure and oxidative stress underlie the Prpf31 splicing factor-related mouse phenotype

  2025cites this paper
• Neuroprotective Effects of 2-Substituted 1, 3-Selenazole Amide Derivatives on Amyloid-Beta-Induced Toxicity in a Transgenic Caenorhabditis Elegans Model of Alzheimer’s Disease

  2021cites this paper
• Age-related alterations on ultrastructure and gene expression profile of the female Blood-Brain Barrier

  2020cites this paper
• Obtaining information from the brain in a non-invasive way: determination of iron in nasal exudate to differentiate hemorrhagic and ischemic strokes

  2019cites this paper
• Biomarkers for Alzheimer's disease and the APOE polymorphism

  2019cites this paper
• Protein phosphatase 2A as therapeutic targets in various disease models

  2018cites this paper
• 17β-estradiol regulates the RNA-binding protein Nova1, which then regulates the alternative splicing of estrogen receptor β in the aging female rat brain.

  2018cites this paper
• Electrostatic Polarization Effect on Cooperative Aggregation of Full Length Human Islet Amyloid

  2018cites this paper
• Molecular Mechanism of Early Amyloid Self-Assembly Revealed by Computational Modeling

  2018cites this paper
• Nano-assembly of amyloid β peptide: role of the hairpin fold

  2017cites this paper
• Alzheimer's Disease: Pathophysiology, Hypotheses and Treatment Strategies

  2016cites this paper
• Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.

  2015cites this paper
• Ejercicio y envejecimiento: cambios transcripcionales y epigenéticos en un modelo murino de envejecimiento acelerado

  2015cites this paper
• Synthesis and Biological Activity of Indolinones

  2014cites this paper
• Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress.

  2013cites this paper
• Brain response to calorie restriction

  2012cites this paper
• Single-particle characterization of Aβ oligomers in solution.

  2012cites this paper
• Cooperativity among Short Amyloid Stretches in Long Amyloidogenic Sequences

  2012cites this paper
• Mitochondrial Dysfunction and Oxidative and Endoplasmic Reticulum Stress in Argyrophilic Grain Disease

  2011cites this paper
• The Search for Biomarkers in Alzheimer's Disease

  2010cites this paper
• Genetic and Blood Biomarkers of Alzheimer`s Disease~!2009-11-10~!2010-01-21~!2010-05-06~!

  2010cites this paper
• Biological Effects of Calorie Restriction: Implications for Modification of Human Aging

  2010cites this paper
• Genetic and Blood Biomarkers of Alzheimer's Disease

  2010cites this paper
• Caloric restriction: from soup to nuts.

  2010cites this paper
• Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics

  2010cites this paper
• The Role of Myosin Va and the Dynein/Dynactin Complex in Neurofilament Axonal Transport

  2009cites this paper
• Amyloid Imaging with PET in Alzheimer’s Disease, Mild Cognitive Impairment, and Clinically Unimpaired Subjects

  2009cites this paper
• Dynein Dysfunction Induces Endocytic Pathology Accompanied by an Increase in Rab GTPases

  2009cites this paper
• Genetic markers of neurodegeneration: a role for paraoxonase 1 in sporadic Alzheimer's disease?

  2009cites this paper
• Molecular Bases of Caloric Restriction Regulation of Neuronal Synaptic Plasticity

  2008cites this paper
• The Role of Alpha-Synuclein in Neurodegenerative Diseases: A Potential Target for New Treatment Strategies?

  2008cites this paper
• Seven-Transmembrane Receptors and Ubiquitination

  2007cites this paper
• Real-time PCR analysis of age-dependent alterations in the RVLM neurotransmitter gene expression profile of F344 rats

  2007cites this paper
• FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

  2007cites this paper
• Chapter 1 – Advances in our Understanding of Neurodegeneration

  2007cites this paper
• Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

  2007cites this paper
• Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

  2007cites this paper
• Proteotoxicity of polyglutamine expansion proteins: Cellular mechanisms and their modulation by molecular chaperones

  2007cites this paper
• Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?

  2007cites this paper
• Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?

  2007cites this paper
• Ageing and neuronal vulnerability

  2006cites this paper
• of G and Mitogen-Activated Kinase Signaling by Ubiquitination: Insights From Model Organisms Heart Failure and Protein Quality Control

  2006cites this paper
• Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins.

  2006cites this paper
• Heart failure and protein quality control.

  2006cites this paper
• The Principal Inferior Olivary Nucleus in Aging and Alzheimer's Disease

  2006influential citation
• A crumpled surface having transverse attractive interactions as a simplified model with biological significance.

  2006cites this paper
• of G and Mitogen-Activated Kinase Signaling by Ubiquitination: Insights From Model Organisms Heart Failure and Protein Quality Control

  2006cites this paper
• Alpha-Synuclein Lesions in Normal Aging, Parkinson Disease, and Alzheimer Disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA)

  2005cites this paper
• Neurotoxic Oxidative Metabolite of Serotonin

  2005influential citation
• Title Alpha-synuclein lesions in normal aging , Parkinson disease , and Alzheimer disease : Evidence from the Baltimore Longitudinal Study of Aging ( BLSA ) Permalink

  2005cites this paper
• Axonal transport defects: a common theme in neurodegenerative diseases

  2005cites this paper
• Assessing Background Ground Water Chemistry beneath a New Unsewered Subdivision

  2005cites this paper
• Neurotoxic protein oligomers — what you see is not always what you get

  2005cites this paper
• Expression Profiling and Pharmacotherapeutic Development in the Central Nervous System

  2004cites this paper
• Protein mis-folding emerges as a "drugable" target for discovery of novel therapies for neuropsychiatric diseases of aging.

  2004cites this paper